• Procalcitonin: Once is not enough — The critical role of serial testing

    CAP Today Webinar, Sponsored by Fujirebio: Highlights and Takeaways

    Presenters:

    • Eric Gluck, M.D., Professor of Medicine, Chief Academic Officer, and Director of Critical Care Service at Swedish Covenant Hospital
    • Mike Broyles, PharmD, Director of Pharmacy and Laboratory Services at Five Rivers Medical Center

    Procalcitonin (PCT) is a superior biomarker of bacterial infection, and serial testing of PCT has been shown to offer clinical benefits and reduce hospital spending by:

    • decreasing length of hospital stays
    • minimizing the number of blood cultures performed
    • shortening the time spent on antibiotic therapy
    • improving the timing of diagnosis and the ability to refine antibiotic treatment accordingly

    Serial measurement of PCT levels is a major innovation for antibiotic stewardship in the battle against antimicrobial resistance. Accurate analysis of circulatory PCT levels is essential to improving diagnosis, treatment, and patient outcomes.